Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Shionogi Pharma Files Baktar Small-Sized Tablets to Improve Compliance in Children
August 31, 2020
- Nichi-Iko to Revamp Quality Control System after Massive Recalls by Leveraging Teva Takeda Plant
August 28, 2020
- MEDRx/D. Western Therapeutics’ Lidocaine Tape Formulation Filed for Post-Herpetic Neuralgia in US
August 28, 2020
- 2 More HIF-PH Inhibitors, Enerzair, Enspryng and More Now Available in Japan
August 27, 2020
- JCR to Commence Full-Fledged Biz for Lysosomal Storage Disorder Meds in Brazil
August 27, 2020
- Kowa’s Glaucoma Med Glanatec Approved in Thailand
August 27, 2020
- As Entresto Hits Japan Market, Novartis Poised to Tap All Channels to Push Global Blockbuster
August 26, 2020
- Carna Bio Starts First-in-Human Trial for BTK Inhibitor
August 26, 2020
- Sanwa Kagaku Files SHPT Med for Japan Approval
August 26, 2020
- Drug Makers Taking Mixed Disclosure Policies for Coronavirus Infections
August 25, 2020
- Takeda to Sell Japan OTC Biz to Blackstone, Weber Says It’s the Right Choice
August 25, 2020
- Takeda to Offload Japan OTC Biz to Blackstone for 242 Billion Yen
August 24, 2020
- Japan Drug Makers’ Q1 Profit Surges on Voluntary Bans on Doctor Calls: Jiho Tally
August 24, 2020
- Japan Approves CureApp’s Smoking Cessation Apps
August 24, 2020
- Long-Term Prescriptions Up for Expectorants, Bronchodilators amid COVID-19 Emergency: Survey
August 24, 2020
- 4 Drug Makers Flag GLP-1 Use for “Weight Loss” after Diabetes Society Warning
August 24, 2020
- BMS Introduces New Corporate Brand in Japan
August 21, 2020
- Viltepso Now Available in US: Nippon Shinyaku
August 21, 2020
- 4 Add’l Products Recalled over Flawed Testing at Kyowa CritiCare
August 20, 2020
- Boehringer’s Ofev Already Hits Japan Peak Sales Outlook, Momentum Likely to Continue with New Indications
August 20, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…